Download PDF
Fortschr Neurol Psychiatr 2018; 86(01): 43-48
DOI: 10.1055/s-0043-110051
Übersicht
Georg Thieme Verlag KG Stuttgart · New York

Fahreignung bei Morbus Parkinson

Driving ability in Parkinson’s disease
Carsten Buhmann
1   Universitätsklinikum Hamburg-Eppendorf, Ambulanzzentrum und Neurologische Klinik
,
Jan Vesper
2   Heinrich-Heine-Universität Dusseldorf, Sektion Funktionelle Neurochirurgie und Stereotaxie
,
Henriette Oelsner
3   Neurologisches Fachkrankenhaus für Bewegungsstörungen/Parkinson; Kliniken-Beelitz GmbH, Psychologie/Neuropsychologie
› Author Affiliations
Further Information

Publication History

Publication Date:
15 August 2017 (online)

    Permissions and Reprints

Zusammenfassung

Etwa 60 % aller Parkinson-Patienten und 50 % der Parkinson-Patienten mit Tiefer Hirnstimulation (THS) und Führerschein fahren aktiv Auto. Parkinsonerkrankte weisen jedoch häufig körperliche und/oder psychische Einschränkungen mit potentiellem Verlust der Fahreignung (syn. Fahrtauglichkeit) auf. Die Fahrfähigkeit (syn. Fahrtüchtigkeit) kann auch durch Parkinson-Medikamente eingeschränkt sein. Vom behandelnden Arzt wird verlangt, seine Patienten hinsichtlich ihrer Fähigkeit, ein Kraftfahrzeug zu führen, zu beraten. Dies ist jedoch in der Praxis schwierig. Zum einen gibt es keine standardisierte, prädiktive Testbatterie zur Beurteilung der Fahreignung, zum anderen korreliert die Ausprägung der motorischen Einschränkung nur unzureichend mit der Fahreignung. Dieser Artikel gibt einen Überblick, welche motorischen und nicht-motorischen Symptome die generelle Fahreignung und/oder die situativ-geprägte Fahrfähigkeit bei M. Parkinson beeinträchtigen können, welche Kriterien eine relative oder absolute Fahruntauglichkeit anzeigen, welche neuropsychologischen Untersuchungen sinnvoll sind und wie Patienten mit THS hinsichtlich der Fahreignung zu bewerten und zu beraten sind.

Abstract

About 60 % of all patients with Parkinson’s disease (PD) and about 50 % of PD patients with deep brain stimulation (DBS) in possession of a driving license are active car-drivers. Parkinson patients, however, often display physical and/or psychological weaknesses that can lead to loss of or reduced driving ability. Driving capability can also be affected by Parkinson medication. The attending physician is therefore obliged to advise his patients regarding their ability to be in command of a vehicle. This however can prove difficult in practice. On the one hand, there is no standardised predictive test battery to evaluate driving capability and on the other, levels of motor impairment do not correlate sufficiently with driving skills. This article will provide an overview of motor and non-motor symptoms that affect general and/or Parkinson’s disease-related driving capability and which criteria demonstrate a temporary or permanent inability to drive. Furthermore, we will highlight which neuropsychological investigations are beneficial and how PD patients with DBS should be evaluated and subsequently advised regarding their driving fitness.

Schlüsselwörter

M. Parkinson - Autofahren - Tiefe Hirnstimulation

Key words

car-driving - deep brain stimulation - Parkinson’s disease
 

  • Literatur

  • 1 Meindorfner C, Korner Y, Moller JC. et al. Driving in Parkinson’s disease: mobility, accidents, and sudden onset of sleep at the wheel. Mov Disord 2005; 20 (07) 832-842
    CrossrefPubMedGoogle Scholar
  • 2 Mattern R, Körner Y, Wagenpfeil T. Fahrtüchtigkeit bei chronischen Erkrankungen – Ärzte in der Pflicht. Dtsch Med Wochenschr 2006; 131 (40) 2200-2201
    PubMedGoogle Scholar
  • 3 Berghaus G, Brenner-Hartmann J. Fahreignung, Fahrsicherheit und deren Begutachtung. In: Madea B, Mußhoff F, Berghaus G. Hrsg. Verkehrsmedizin: Fahreignung, Fahrsicherheit, Unfallrekonstruktion. Deutscher Ärzte-Verlag; 2012: 131-143
    Google Scholar
  • 4 Cordell R, Lee HC, Granger A. et al. Driving assessment in Parkinson’s disease-a novel predictor of performance?. Mov Disord 2008; 23 (09) 1217-1222
    CrossrefPubMedGoogle Scholar
  • 5 Uc EY, Rizzo M, Johnson AM. et al. Road safety in drivers with Parkinson disease. Neurology 2009; 73 (24) 2112-2119
    CrossrefPubMedGoogle Scholar
  • 6 Wood JM, Worringham C, Kerr G. et al. Quantitative assessment of driving performance in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2005; 76 (02) 176-180
    CrossrefPubMedGoogle Scholar
  • 7 Crizzle AM, Classen S, Uc EY. Parkinson disease and driving: An evidence-based review. Neurology 2012; 79 (20) 2067-2074
    CrossrefPubMedGoogle Scholar
  • 8 Heikkila VM, Turkka J, Korpelainen J. et al. Decreased driving ability in people with Parkinson’s disease. J Neurol Neurosurg Psychiatry 1998; 64 (03) 325-330
    CrossrefPubMedGoogle Scholar
  • 9 Klimkeit EI, Bradshaw JL, Charlton J. et al. Driving ability in Parkinson’s disease: current status of research. Neurosci Biobehav Rev 2009; 33 (03) 223-231
    CrossrefPubMedGoogle Scholar
  • 10 Gräcmann N, Albrecht M. Begutachtungs-Leitlinien zur Kraftfahrereignung. Letzte Änderung am 2. November 2009 ed. Bundesanstalt für Straßenwesen (BASt): Carl Schünemann Verlag GmbH; 2010
    Google Scholar
  • 11 Singh R, Pentland B, Hunter J. et al. Parkinson’s disease and driving ability. J Neurol Neurosurg Psychiatry 2007; 78 (04) 363-366
    CrossrefPubMedGoogle Scholar
  • 12 Buhmann C, Gerloff C. Autofahren bei Morbus Parkinson – Driving with Parkinson’s Disease. Aktuelle Neurologie 2013; (40) 315-320
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Dubinsky RM, Gray C, Husted D. et al. Driving in Parkinson’s disease. Neurology 1991; 41 (04) 517-520
    CrossrefPubMedGoogle Scholar
  • 14 Worringham CJ, Wood JM, Kerr GK. et al. Predictors of driving assessment outcome in Parkinson’s disease. Mov Disord 2006; 21 (02) 230-235
    CrossrefPubMedGoogle Scholar
  • 15 Uc EY, Rizzo M, Anderson SW. et al. Driving under low-contrast visibility conditions in Parkinson disease. Neurology 2009; 73 (14) 1103-1110
    CrossrefPubMedGoogle Scholar
  • 16 Archibald NK, Clarke MP, Mosimann UP. et al. Visual symptoms in Parkinson’s disease and Parkinson’s disease dementia. Mov Disord 2011; 26 (13) 2387-2395
    CrossrefPubMedGoogle Scholar
  • 17 Uc EY, Rizzo M, Anderson SW. et al. Impaired visual search in drivers with Parkinson’s disease. Ann Neurol 2006; 60 (04) 407-413
    CrossrefPubMedGoogle Scholar
  • 18 Archibald NK, Hutton SB, Clarke MP. et al. Visual exploration in Parkinson’s disease and Parkinson’s disease dementia. Brain 2013; 136: 739-750
    CrossrefPubMedGoogle Scholar
  • 19 Chaudhuri KR, Prieto-Jurcynska C, Naidu Y. et al. The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 2010; 25 (06) 704-709
    CrossrefPubMedGoogle Scholar
  • 20 Amick MM, Grace J, Ott BR. Visual and cognitive predictors of driving safety in Parkinson’s disease patients. Arch Clin Neuropsychol 2007; 22 (08) 957-967
    CrossrefPubMedGoogle Scholar
  • 21 Uitti RJ. Parkinson’s disease and issues related to driving. Parkinsonism Relat Disord 2009; 15 (Suppl. 03) 122-125
    CrossrefPubMedGoogle Scholar
  • 22 Crucian GP, Armaghani S, Armaghani A. et al. Visual-spatial disembedding in Parkinson’s disease. J Clin Exp Neuropsychol 2010; 32 (02) 190-200
    CrossrefPubMedGoogle Scholar
  • 23 Razmy A, Lang AE, Shapiro CM. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol 2004; 61 (01) 97-102
    CrossrefPubMedGoogle Scholar
  • 24 Ondo WG, Dat VK, Khan H. et al. Daytime sleepiness and other sleep disorders in Parkinson’s disease. Neurology 2001; 57 (08) 1392-1396
    CrossrefPubMedGoogle Scholar
  • 25 Paus S, Brecht HM, Koster J. et al. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson’s disease. Mov Disord 2003; 18 (06) 659-667
    CrossrefPubMedGoogle Scholar
  • 26 Weintraub D, Koester J, Potenza MN. et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010; 67 (05) 589-595
    CrossrefPubMedGoogle Scholar
  • 27 Avanzi M, Baratti M, Cabrini S. et al. The thrill of reckless driving in patients with Parkinson’s disease: an additional behavioural phenomenon in dopamine dysregulation syndrome?. Parkinsonism Relat Disord 2008; 14 (03) 257-258
    CrossrefPubMedGoogle Scholar
  • 28 Schuepbach WM, Rau J, Knudsen K. et al. Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med 2013; 368 (07) 610-622
    CrossrefPubMedGoogle Scholar
  • 29 Deuschl G, Schade-Brittinger C, Krack P. et al. A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 2006; 355 (09) 896-908
    CrossrefPubMedGoogle Scholar
  • 30 Buhmann C, Vettorazzi E, Oehlwein C. et al. Impact of Deep Brain Stimulation on Daily Routine Driving Practice in Patients with Parkinson’s Disease. Parkinsons Dis 2015; 608961
    PubMedGoogle Scholar
  • 31 Follett KA, Weaver FM, Stern M. et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med 2010; 362 (22) 2077-2091
    CrossrefPubMedGoogle Scholar
  • 32 Weaver FM, Follett K, Stern M. et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009; 301 (01) 63-73
    CrossrefPubMedGoogle Scholar
  • 33 Williams A, Gill S, Varma T. et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson’s disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol 2010; 9 (06) 581-591
    CrossrefPubMedGoogle Scholar
  • 34 Parsons TD, Rogers SA, Braaten AJ. et al. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson’s disease: a meta-analysis. Lancet Neurol 2006; 5 (07) 578-588
    CrossrefPubMedGoogle Scholar
  • 35 Witt K, Daniels C, Reiff J. et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: a randomised, multicentre study. Lancet Neurol 2008; 07 (07) 605-614
    CrossrefPubMedGoogle Scholar
  • 36 Cavanagh JF, Wiecki TV, Cohen MX. et al. Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold. Nat Neurosci 2011; 14 (11) 1462-1467
    CrossrefPubMedGoogle Scholar
  • 37 Frank MJ, Samanta J, Moustafa AA. et al. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007; 318 (5854) 1309-1312
    CrossrefPubMedGoogle Scholar
  • 38 Buhmann C, Maintz L, Hierling J. et al. Effect of subthalamic nucleus deep brain stimulation on driving in Parkinson disease. Neurology 2014; 82 (01) 32-40
    CrossrefPubMedGoogle Scholar
  • 39 Buhmann C, Gerloff C. Could deep brain stimulation help with driving for patients with Parkinson’s?. Expert Rev Med Devices 2014; 11 (05) 427-429
    CrossrefPubMedGoogle Scholar
  • 40 Buhmann C, Oelsner H, Vesper J. Neurologische Leitlinie „Tiefe Hirnstimulation (THS)und Autofahren bei Morbus Parkinson“ der Arbeitsgemeinschaft Tiefe Hirnstimulation e. V. 15.4.2017.
    PubMedGoogle Scholar
  • 41 Schubert W, Schneider W, Eisenmenger W, Stephan E. Begutachtungsleitlinien zur Kraftfahrereignung – Kommentar. Überarbeitete und erweiterte. 2. Auflage. Kirschbaum Verlag Bonn; 2005
    Google Scholar
  • 42 Fries W, Netz J, Bötzel K. et al. Leitlinie zur Beurteilung der Fahreignung bei neurologischen Erkrankungen. Akt Neurol 2005; 32 (06) 342-350
    Article in Thieme ConnectPubMedGoogle Scholar
  • 43 Ciura T. Standardisierte Hamburger Fahrprobe im Rahmen einer verkehrsmedizinischen ärztlichen Untersuchung gem. Fahrerlaubnisverordnung. Verkehrsinstitut Hanse GmbH – Team Fahrschule; 2010
    Google Scholar
  • 44 Kalbe E, Petrelli A. Kognition bei M. Parkinson. Zeitschrift f Neuropsych 2014; 25 (01) 17-30
    PubMedGoogle Scholar
  • 45 Niemann S, Hartje W. Fahreignung bei neurologischen Erkrankungen. Göttingen: Hogrefe; 2016
    Google Scholar
  • 46 Mattis S. Dementia Rating Scale: Professional Manual (Vol.2). Psychological Assessment Ressources; Florida: 1988
    Google Scholar
  • 47 Kalbe E, Kessler J, Calabrese P. et al. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry 2004; 19 (02) 136-143
    CrossrefPubMedGoogle Scholar
  • 48 Nasreddine ZS, Phillips NA, Bedirian V. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53 (04) 695-699
    CrossrefPubMedGoogle Scholar
  • 49 Classen S, Witter DP, Lanford DN. et al. Usefulness of screening tools for predicting driving performance in people with Parkinson’s disease. Am J Occup Ther 2011; 65 (05) 579-588
    CrossrefPubMedGoogle Scholar
  • 50 Lachenmayer L. Parkinson’s disease and the ability to drive. J Neurol 2000; 247 (Suppl. 04) 28-30
    CrossrefPubMedGoogle Scholar
  • 51 Zimmermann P, Fimm B. Testbatterie zur Aufmerksamkeitsprüfung, Version Mobilität. Herzogenrath; 2008
    Google Scholar
  • 52 Paulitsch C. Psychologische Apparate. Passau: Universitätsverlag; 2006
    Google Scholar
  • 53 Strauss E, Sherman E, Spreen O. A compendium of Neuropsychological Tests. 3. ed.. New York: Oxford University Press; 2006
    Google Scholar
  • 54 Aschenbrenner S, Tucha O, Lange KW. Regensburger Wortflüssigkeits-Test (RWT). Göttingen: Hogrefe; 2000
    Google Scholar